HCA Healthcare Inc
NYSE:HCA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
246.65
415.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
HCA Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for HCA is 418.79 USD with a low forecast of 362.59 USD and a high forecast of 483 USD.
HCA Last Price Targets
HCA Healthcare Inc
The latest public price target was made on Oct 28, 2024 by Michael Wiederhorn from Oppenheimer , who expects HCA stock to rise by 23% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Michael Wiederhorn
Oppenheimer
|
400
USD
Upside 23% |
3 weeks ago
Oct 28, 2024
|
HCA Healthcare Inc (HCA) PT Raised to $400 at Oppenheimer
StreetInsider
|
Ann Hynes
Mizuho Securities
|
425
USD
Upside 31% |
3 weeks ago
Oct 28, 2024
|
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
StreetInsider
|
Matthew Gillmor
KeyBanc
|
420
USD
Upside 29% |
3 weeks ago
Oct 28, 2024
|
HCA Healthcare Inc (HCA) PT Lowered to $420 at KeyBanc
StreetInsider
|
Matthew Gillmor
KeyBanc
|
475
USD
Upside 46% |
1 month ago
Oct 10, 2024
|
HCA Healthcare initiated with an Overweight at KeyBanc
TheFly
|
Pito Chickering
Deutsche Bank
|
441
USD
Upside 36% |
1 month ago
Oct 1, 2024
|
Deutsche Bank Reiterates Buy Rating on HCA Healthcare Inc (HCA)
StreetInsider
|
David MacDonald
Truist Financial
|
430
USD
Upside 32% |
3 months ago
Aug 19, 2024
|
HCA Healthcare price target raised to $430 from $390 at Truist
TheFly
|
Pito Chickering
Deutsche Bank
|
375
USD
Upside 15% |
4 months ago
Jun 28, 2024
|
HCA Healthcare price target raised to $375 from $359 at Deutsche Bank
TheFly
|
Brian Tanquilut
Jefferies
|
390
USD
Upside 20% |
5 months ago
Jun 6, 2024
|
HCA Holdings (HCA) PT Raised to $390 at Jefferies
StreetInsider
|
Michael Wiederhorn
Oppenheimer
|
345
USD
Upside 6% |
6 months ago
Apr 29, 2024
|
HCA Healthcare price target raised to $345 from $330 at Oppenheimer
TheFly
|
Ben Hendrix
RBC Capital
|
329
USD
Upside 1% |
6 months ago
Apr 29, 2024
|
HCA Healthcare price target raised to $329 from $322 at RBC Capital
TheFly
|
Pito Chickering
Deutsche Bank
|
359
USD
Upside 10% |
7 months ago
Apr 12, 2024
|
HCA Holdings (HCA) PT Raised to $359 at Deutsche Bank
StreetInsider
|
Michael Wiederhorn
Oppenheimer
|
310
USD
Downside 5% |
1 year ago
Apr 24, 2023
|
HCA Healthcare Price Estimates Raised On Strong Performance And Optimistic Outlook
Benzinga
|
Ben Hendrix
RBC Capital
|
315
USD
Downside 3% |
1 year ago
Apr 24, 2023
|
HCA Healthcare Price Estimates Raised On Strong Performance And Optimistic Outlook
Benzinga
|
Ann Hynes
Mizuho Securities
|
298
USD
Downside 8% |
1 year ago
Apr 24, 2023
|
HCA Healthcare Price Estimates Raised On Strong Performance And Optimistic Outlook
Benzinga
|
Unknown Analyst
Goldman Sachs
|
296
USD
Downside 9% |
1 year ago
Feb 8, 2023
|
Goldman Sachs Maintains Buy on HCA Healthcare, Raises Price Target to $296
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCA's stock price target?
Price Target
418.79
USD
According to Wall Street analysts, the average 1-year price target for HCA is 418.79 USD with a low forecast of 362.59 USD and a high forecast of 483 USD.
What is HCA Healthcare Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for HCA Healthcare Inc's revenue is 6%. The projected CAGR for the next 3 years is 7%.
What is HCA Healthcare Inc's Operating Income forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for HCA Healthcare Inc's operating income is 6%. The projected CAGR for the next 3 years is 8%.
What is HCA Healthcare Inc's Net Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for HCA Healthcare Inc's net income is 12%. The projected CAGR for the next 3 years is 10%.